Ava Keyvani Chahi

Ava Keyvani Chahi

Auto-generated profile, based on publicly available information

Ava Keyvani Chahi

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Blood Cancer Discovery
Verified
Journal Article
Open access
PDF file
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Acute myeloid leukemia (AML) is fueled by leukemic stem cells (LSC) whose determinants are challenging to discern from hematopoietic stem cells (HSC) or uncover by approaches focused on general cell properties. We have identified a set of RNA-binding proteins (RBP) selectively enriched in human AML LSCs. Using an in vivo two-step CRISPR-Cas9 screen to assay stem cell functionality, we found 32 RBPs essential for LSCs in MLL-AF9;NrasG12D AML. Loss-of-function approaches targeting key hit RBP ELAVL1 compromised LSC-driven in vivo leukemic reconstitution, and selectively depleted primitive malignant versus healthy cells. Integrative multiomics revealed differentiation, splicing, and mitochondrial metabolism as key features defining the leukemic ELAVL1–mRNA interactome with mitochondrial import protein, TOMM34, being a direct ELAVL1-stabilized target whose repression impairs AML propagation. Altogether, using a stem cell–adapted in vivo CRISPR screen, this work demonstrates pervasive reliance on RBPs as regulators of LSCs and highlights their potential as therapeutic targets in AML. Significance: LSC-targeted therapies remain a significant unmet need in AML. We developed a stem-cell–adapted in vivo CRISPR screen to identify key LSC drivers. We uncover widespread RNA-binding protein dependencies in LSCs, including ELAVL1, which we identify as a novel therapeutic vulnerability through its regulation of mitochondrial metabolism. This article is highlighted in the In This Issue feature, p. 171

1 May 2023
Verified
Other
Open access
PDF file
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Supplemental Figure S6 shows the GSEA of ELAVL1 depletion in mouse RN2c and human primary AML cells, ELAVL1 subcellular localization in mouse and human AML, the qRT-PCR of ELAVL1 targets in MS-444-treated RN2c cells, and the integrative analysis of the mouse RNA-seq and eCLIP-seq.

1 May 2023
Verified
Other
Open access
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Table S9 shows the (a) differentially expressed transcripts and (b) altered pathways as identified by GSEA from the ELAVL1 knockdown human primary AML RNA-sequencing data set.

1 May 2023
Verified
Other
Open access
PDF file
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Supplemental Figure S1 shows expression of RBPs in healthy HSPCs and RN2c cells, sgRNA drop out dynamics in primary and secondary transplants, the molecular functions and biological processes associated with the hit RBPs and their gene essentialities.

1 May 2023
Verified
Other
Open access
PDF file
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Supplemental Figure S3 shows the generation of the bcCML mouse model and the effects of ELAVL1 on normal bone marrow in vivo.

1 May 2023
Verified
Other
Open access
AVAna Vujovic
Ana Vujovic
LRLaura de Rooij
Laura de Rooij
ACAva Keyvani Chahi
Ava Keyvani Chahi
HCHe Tian Chen
He Tian Chen
BYBrian A. Yee
Brian A. Yee
KHKristin J. Hope
Kristin J. Hope
Table S3 shows clinical information for all AML patient specimens used in this study.